博士伦的动态

Exciting News for the Glaucoma Community! ?? Glaukos Corporation's innovative iDose TR implant is now commercially available. iDose bridges the gap between surgical & pharmaceutical Glaucoma treatment, being an implantable device that administers minute doses of Travopost directly to the target tissue to lower IOP for extended periods. This device based approach eliminates issues of patience non-adherence and reduces side-effects sustained from the direct application of drugs to the eye for long periods of time. Jay Katz, Glaukos's CMO described this launch as a "Monumental Step forward that we've been waiting for and anticipated for years". It will be interesting to see how this product launch will alter the way ophthalmologists approach the treatment of Glaucoma. https://lnkd.in/gmbtzp9p #glaucoma #ophthalmology #innovation #medicaldevices

?? Unlock Radiology Insights with MHN's Expert Panel! ?? Attention pharmaceutical brands and insight agencies! Are you searching for comprehensive insights in the realm of radiology? Look no further than MHN's specialized panel of radiologists. Plan your project here: https://lnkd.in/er-_cxKu In the dynamic landscape of pharmaceuticals, understanding the nuances of medical imaging trends and innovations is crucial. With MHN's panel, gain access to a wealth of expertise that can elevate your research strategies and provide actionable insights. Whether you're exploring new pharmaceutical developments, testing marketing strategies, or seeking to understand the evolving needs of healthcare professionals, MHN's radiology panel offers the depth and breadth of knowledge you need. Partner with us to harness the power of radiology insights and drive informed decision-making in your pharmaceutical endeavors. With MHN, you'll discover a world of possibilities for better insights and impactful strategies. Reach out to us today to start your journey towards success! #RadiologyInsights #PharmaResearch #MedicalImaging ?????? #RepresentativeSamples #MarketResearch ???? #QualitativeResearch #QuantitativeResearch #MHN #MHNInsights

?? Unlock Radiology Insights with MHN's Expert Panel! ?? Attention pharmaceutical brands and insight agencies! Are you searching for comprehensive insights in the realm of radiology? Look no further than MHN's specialized panel of radiologists. Plan your project here: https://lnkd.in/er-_cxKu In the dynamic landscape of pharmaceuticals, understanding the nuances of medical imaging trends and innovations is crucial. With MHN's panel, gain access to a wealth of expertise that can elevate your research strategies and provide actionable insights. Whether you're exploring new pharmaceutical developments, testing marketing strategies, or seeking to understand the evolving needs of healthcare professionals, MHN's radiology panel offers the depth and breadth of knowledge you need. Partner with us to harness the power of radiology insights and drive informed decision-making in your pharmaceutical endeavors. With MHN, you'll discover a world of possibilities for better insights and impactful strategies. Reach out to us today to start your journey towards success! #RadiologyInsights #PharmaResearch #MedicalImaging ?????? #RepresentativeSamples #MarketResearch ???? #QualitativeResearch #QuantitativeResearch #MHN #MHNInsights

?? Unlock Radiology Insights with MHN's Expert Panel! ?? Attention pharmaceutical brands and insight agencies! Are you searching for comprehensive insights in the realm of radiology? Look no further than MHN's specialized panel of radiologists. In the dynamic landscape of pharmaceuticals, understanding the nuances of medical imaging trends and innovations is crucial. With MHN's panel, gain access to a wealth of expertise that can elevate your research strategies and provide actionable insights. Whether you're exploring new pharmaceutical developments, testing marketing strategies, or seeking to understand the evolving needs of healthcare professionals, MHN's radiology panel offers the depth and breadth of knowledge you need. Partner with us to harness the power of radiology insights and drive informed decision-making in your pharmaceutical endeavors. With MHN, you'll discover a world of possibilities for better insights and impactful strategies. Reach out to us today to start your journey towards success! #RadiologyInsights #PharmaResearch #MedicalImaging ??????

“AI At Johnson & Johnson – Current Investments” https://lnkd.in/eYPMQEA Johnson & Johnson (J&J) is the largest pharmaceutical firm by revenue. In this article, we’re going to take a look at the known AI-related investments of Johnson & Johnson in the two areas where they seem to be most active today: - Drug development - Robotic surgery #artificialintelligence #AI #drugdevelopment #roboticsurgery #lifesciences #pharmaceutical #healthcare

?? Unlock Radiology Insights with MHN's Expert Panel! ?? Attention pharmaceutical brands and insight agencies! Are you searching for comprehensive insights in the realm of radiology? Look no further than MHN's specialized panel of radiologists. In the dynamic landscape of pharmaceuticals, understanding the nuances of medical imaging trends and innovations is crucial. With MHN's panel, gain access to a wealth of expertise that can elevate your research strategies and provide actionable insights. Whether you're exploring new pharmaceutical developments, testing marketing strategies, or seeking to understand the evolving needs of healthcare professionals, MHN's radiology panel offers the depth and breadth of knowledge you need. Partner with us to harness the power of radiology insights and drive informed decision-making in your pharmaceutical endeavors. With MHN, you'll discover a world of possibilities for better insights and impactful strategies. Reach out to us today to start your journey towards success! #RadiologyInsights #PharmaResearch #MedicalImaging ?????? #RepresentativeSamples #MarketResearch ???? #QualitativeResearch #QuantitativeResearch #MHN #MHNInsights

#NEWS: Johnson & Johnson has co-led the Series D funding of Orasis Pharmaceuticals, an emerging ophthalmic pharmaceutical company with an FDA approved prescription eye drop, QLOSI? (pilocarpine hydrochloride ophthalmic solution) 0.4%, to treat presbyopia in adults.? ? Presbyopia, the gradual loss of the eye’s ability to focus on near objects, which begins to affect most adults sometime after the age of 40, impacts 128 million people in the US, and 1.9 billion people globally increasing to 2.1 billion by 2030.? ? Our investment in Orasis Pharmaceuticals explores a novel and flexible treatment option for adults to manage their presbyopia, building on our robust offering of innovative solutions in this area of high need.? ? We’re excited for this investment in presbyopia innovation as it further supports our efforts to transform the patient experience and create new standards of care in ophthalmology. Learn More: https://lnkd.in/eb8YzwHE

Case Study: Insights into the Ophthalmology Market in France Uncover the complexities of the ophthalmology market in France with Med Planet's ground breaking qualitative research! Our client, a leading pharmaceutical company, sought insights into the potential replacement of Lucentis or Avastin in the treatment of Age-Related Macular Degeneration (AMD) with a new Monoclonal Antibody (MAB). Despite challenges surrounding secrecy and market confusion, we were able to use a strategic approach. Leveraging our established partnerships with key payer entities and expert moderators, we delved deep into the nuances of the market landscape. View the full case Study > https://hubs.ly/Q02wMGbd0 #HealthcareResearch #MedPlanetInsights #CaseStudy

Today we released our 2024 Biosimilars Report. The availability of #biosimilars means greater patient access and cost savings to the healthcare system. In this report, we outline the latest industry data on biosimilar adoption and savings, provide expert commentary, best practices, and share new research into biosimilar utilization in ophthalmology. Craig Cowman, EVP, Pharmaceutical & Specialty Solutions talks about Cardinal Health’s role in biosimilars. You can find the report here: https://spr.ly/6047XJhu5

With new research derived from surveys and interviews with 80 retina specialists, the?2024 Biosimilars Report: insights on a pivotal year of evolution and expansion offers thought-provoking analysis, insights into market growth, drivers of adoption and remaining barriers to widespread adoption. Read it now.??